Literature DB >> 8050825

Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells.

P Kloen1, C L Jennings, M C Gebhardt, D S Springfield, H J Mankin.   

Abstract

Transforming growth factor-beta (TGF-beta) is a polypeptide with multiple physiological functions. Isoforms of this growth factor have important roles in control of the cell cycle, in regulation of cell-cell interactions and in growth and development. Malignant transformation has been shown to be associated with increased expression of TGF-beta. Since bone is the largest storage site and producer of TGF-beta, we speculated on the existence of an autocrine mechanism in osteosarcoma, a malignant bone tumor. Expression of TGF-beta cell surface receptors, effects on growth of TGF-beta and TGF-beta antibodies and production of 2 TGF-beta isoforms were studied in a panel of 7 osteosarcoma cell lines. In contrast to most previous reports on the effects of TGF-beta on osteosarcoma cell growth, we found a mitogenic effect of TGF-beta 1 in 4 of 7 osteosarcoma cell lines. Receptor profiles for TGF-beta were aberrant in 5 of the 7 cell lines tested, and production of TGF-beta 1 and TGF-beta 2 varied among cell lines. Addition of anti-TGF-beta antagonized the effects of endogenous TGF-beta. Our results suggest a potential role of TGF-beta in autocrine growth control of osteosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050825     DOI: 10.1002/ijc.2910580323

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population.

Authors:  Yun-Sheng Hu; Yong Pan; Wen-Hai Li; Yong Zhang; Jun Li; Bao-An Ma
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

2.  Construction of antisense transforming growth factor beta 1 gene and its effect on the proliferation by expression in osteosarcoma cells.

Authors:  Yong Liu; Qixin Zheng; Jingyuan Du; Shuhua Yang; Zengwu Shao; Baojun Xiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

3.  Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.

Authors:  Yun-Sheng Hu; Yong Pan; Wen-Hai Li; Yong Zhang; Jun Li; Bao-An Ma
Journal:  BMC Cancer       Date:  2010-04-29       Impact factor: 4.430

4.  The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration.

Authors:  Jun Chen; Yang Song; Jing Yang; Li Gong; Peng Zhao; Yong Zhang; Haichuan Su
Journal:  Mol Cell Biochem       Date:  2013-09-14       Impact factor: 3.396

5.  Pro-tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma.

Authors:  R F Portela; B A Fadl-Alla; H C Pondenis; M L Byrum; L D Garrett; K L Wycislo; L B Borst; T M Fan
Journal:  J Vet Intern Med       Date:  2014-03-31       Impact factor: 3.333

Review 6.  Review of Osteosarcoma and Current Management.

Authors:  Ryan A Durfee; Maryam Mohammed; Hue H Luu
Journal:  Rheumatol Ther       Date:  2016-10-19

7.  Upregulation and biological function of transmembrane protein 119 in osteosarcoma.

Authors:  Zhen-Huan Jiang; Jun Peng; Hui-Lin Yang; Xing-Li Fu; Jin-Zhi Wang; Lei Liu; Jian-Nong Jiang; Yong-Fei Tan; Zhi-Jun Ge
Journal:  Exp Mol Med       Date:  2017-05-12       Impact factor: 8.718

8.  Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.

Authors:  F Navid; J J Letterio; C L Yeung; M Pegtel; L J Helman
Journal:  Sarcoma       Date:  2000

Review 9.  Melatonin: an anti-tumor agent for osteosarcoma.

Authors:  Hadis Fathizadeh; Hamed Mirzaei; Zatollah Asemi
Journal:  Cancer Cell Int       Date:  2019-11-29       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.